Phase 4 Trial of Miltefosine for the Treatment of Indian Visceral Leishmaniasis
The Journal of Infectious Diseases2007Vol. 196(4), pp. 591–598
Citations Over TimeTop 1% of 2007 papers
Sujit Bhattacharya, Prabhat Kumar Sinha, Shyam Sundar, Chandreshar Prasad Thakur, T. K. Jha, Krishna Pandey, Vidyanand Rabi Das, Naveen Kumar, Chandrasekhar Lal, Neena Verma, Vijay Pratap Singh, Alok Ranjan, Rakesh Bihari Verma, Gerlind Anders, H. Sindermann, Nirmal Kumar Ganguly
Abstract
This study supports the use of miltefosine in an outpatient setting in an area where VL is endemic.
Related Papers
- → Relapse of Visceral Leishmaniasis after Miltefosine Treatment in a Nepalese Patient(2009)73 cited
- → Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine(2009)26 cited
- → Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis(2016)12 cited
- → Oral miltefosine treatment in children with visceral leishmaniasis: a brief review(2008)25 cited
- → A case report on Para-kala-azar dermal leishmaniasis: an unresolved mystery(2023)